Nature Medicine outlines strategic research agenda for human microbiome

A strategic international vision published by Nature Medicine on October 23, 2026, proposes ten priorities to guide research and public health policies regarding the human microbiome. Developed by experts convened by the U.S. Department of Health and Human Services, the agenda aims to translate microbial knowledge into concrete actions for preventing chronic diseases and rigorously evaluating microbiome interventions.

The human microbiome, comprising microorganisms living in and on the body, plays a critical role in digestion, metabolism, and immune system modulation. Research increasingly links alterations in the gut microbiota to conditions such as obesity, type 2 diabetes, irritable bowel syndrome, inflammatory bowel diseases, and mood disorders. The strategic roadmap emphasizes the importance of pregnancy, early childhood, nutrition, and appropriate drug use in maintaining microbial health.

Beyond metabolic functions, the microbiota provides protective, structural, and immunological benefits. The agenda seeks to clarify causal relationships between microbial changes and chronic diseases, including potential links to the efficacy and side effects of certain chemotherapies and immunotherapies.